BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31629677)

  • 1. TGFβ induces stemness through non-canonical AKT-FOXO3a axis in oral squamous cell carcinoma.
    Li K; Yang L; Li J; Guan C; Zhang S; Lao X; Ouyang D; Zheng G; Gao S; Wang D; Liang Y; Liao G
    EBioMedicine; 2019 Oct; 48():70-80. PubMed ID: 31629677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Akt-FOXO3a signaling axis dysregulation in human oral squamous cell carcinoma and potent efficacy of FOXO3a-targeted gene therapy.
    Fang L; Wang H; Zhou L; Yu D
    Oral Oncol; 2011 Jan; 47(1):16-21. PubMed ID: 21109483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ZNF677 inhibits oral squamous cell carcinoma growth and tumor stemness by regulating FOXO3a.
    Zhang Z; Zhang Y; Hu X; Chen Y; Zhuang L; Zhang S
    Hum Cell; 2023 Jul; 36(4):1464-1476. PubMed ID: 37129799
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pitavastatin induces apoptosis in oral squamous cell carcinoma through activation of FOXO3a.
    Lee N; Tilija Pun N; Jang WJ; Bae JW; Jeong CH
    J Cell Mol Med; 2020 Jun; 24(12):7055-7066. PubMed ID: 32406610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FOXO3a reactivation mediates the synergistic cytotoxic effects of rapamycin and cisplatin in oral squamous cell carcinoma cells.
    Fang L; Wang H; Zhou L; Yu D
    Toxicol Appl Pharmacol; 2011 Feb; 251(1):8-15. PubMed ID: 21092744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the non-canonical AKT-FOXO3a axis: A potential therapeutic strategy for oral squamous cell carcinoma.
    Liu Y
    EBioMedicine; 2019 Nov; 49():6-8. PubMed ID: 31648985
    [No Abstract]   [Full Text] [Related]  

  • 7. miR-194 regulated AGK and inhibited cell proliferation of oral squamous cell carcinoma by reducing PI3K-Akt-FoxO3a signaling.
    Chi H
    Biomed Pharmacother; 2015 Apr; 71():53-7. PubMed ID: 25960215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppression of miR-204 enables oral squamous cell carcinomas to promote cancer stemness, EMT traits, and lymph node metastasis.
    Yu CC; Chen PN; Peng CY; Yu CH; Chou MY
    Oncotarget; 2016 Apr; 7(15):20180-92. PubMed ID: 26933999
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GLI3 knockdown decreases stemness, cell proliferation and invasion in oral squamous cell carcinoma.
    Rodrigues MFSD; Miguita L; De Andrade NP; Heguedusch D; Rodini CO; Moyses RA; Toporcov TN; Gama RR; Tajara EE; Nunes FD
    Int J Oncol; 2018 Dec; 53(6):2458-2472. PubMed ID: 30272273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DYRK1A is required for maintenance of cancer stemness, contributing to tumorigenic potential in oral/oropharyngeal squamous cell carcinoma.
    Martin CE; Nguyen A; Kang MK; Kim RH; Park NH; Shin KH
    Exp Cell Res; 2021 Aug; 405(1):112656. PubMed ID: 34033760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoids induce antagonism between FOXO3A and FOXM1 transcription factors in human oral squamous cell carcinoma (OSCC) cells.
    Osei-Sarfo K; Gudas LJ
    PLoS One; 2019; 14(4):e0215234. PubMed ID: 30978209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interplay between ΔNp63 and miR-138-5p regulates growth, metastasis and stemness of oral squamous cell carcinoma.
    Zhuang Z; Xie N; Hu J; Yu P; Wang C; Hu X; Han X; Hou J; Huang H; Liu X
    Oncotarget; 2017 Mar; 8(13):21954-21973. PubMed ID: 28423539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma.
    Tsai LL; Yu CC; Chang YC; Yu CH; Chou MY
    J Oral Pathol Med; 2011 Sep; 40(8):621-8. PubMed ID: 21342274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small-Molecule ONC201/TIC10 Targets Chemotherapy-Resistant Colorectal Cancer Stem-like Cells in an Akt/Foxo3a/TRAIL-Dependent Manner.
    Prabhu VV; Allen JE; Dicker DT; El-Deiry WS
    Cancer Res; 2015 Apr; 75(7):1423-32. PubMed ID: 25712124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-186 serves as a tumor suppressor in oral squamous cell carcinoma by negatively regulating the protein tyrosine phosphatase SHP2 expression.
    Cai Z; Hao XY; Liu FX
    Arch Oral Biol; 2018 May; 89():20-25. PubMed ID: 29407635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lactate Promotes Cancer Stem-like Property of Oral Sequamous Cell Carcinoma.
    Zhao H; Hu CY; Chen WM; Huang P
    Curr Med Sci; 2019 Jun; 39(3):403-409. PubMed ID: 31209810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma.
    Chiou SH; Yu CC; Huang CY; Lin SC; Liu CJ; Tsai TH; Chou SH; Chien CS; Ku HH; Lo JF
    Clin Cancer Res; 2008 Jul; 14(13):4085-95. PubMed ID: 18593985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hedgehog and TGFβ signaling converge on Gli2 to control bony invasion and bone destruction in oral squamous cell carcinoma.
    Cannonier SA; Gonzales CB; Ely K; Guelcher SA; Sterling JA
    Oncotarget; 2016 Nov; 7(46):76062-76075. PubMed ID: 27738315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of cancer stem-like and epithelial-mesenchymal transdifferentiation property in oral epithelial cells with long-term nicotine exposure: reversal by targeting SNAIL.
    Yu CC; Chang YC
    Toxicol Appl Pharmacol; 2013 Feb; 266(3):459-69. PubMed ID: 23219715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated expression of JMJD6 is associated with oral carcinogenesis and maintains cancer stemness properties.
    Lee CR; Lee SH; Rigas NK; Kim RH; Kang MK; Park NH; Shin KH
    Carcinogenesis; 2016 Feb; 37(2):119-128. PubMed ID: 26645717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.